S Wallner, G Schmitz - Chemistry and physics of lipids, 2011 - Elsevier
Plasmalogens are a class of phospholipids carrying a vinyl ether bond in sn-1 and an ester bond in sn-2 position of the glycerol backbone. Although they are widespread in all tissues …
P Brites, HR Waterham, RJA Wanders - … BBA)-Molecular and Cell Biology of …, 2004 - Elsevier
Plasmalogens (1-O-alk-1′-enyl-2-acyl glycerophospholipids) constitute a special class of phospholipids characterized by the presence of a vinyl–ether bond at the sn-1 position …
KP Su, SY Huang, TH Chiu, KC Huang… - Journal of Clinical …, 2008 - psychiatrist.com
Background: Perinatal depression is common, and treatment remains challenging. Depression has been reported to be associated with the abnormality of omega-3 …
AA Farooqui, WY Ong, LA Horrocks - Pharmacological reviews, 2006 - ASPET
The phospholipase A2 family includes secretory phospholipase A2, cytosolic phospholipase A2, plasmalogen-selective phospholipase A2, and calcium-independent phospholipase A2 …
The monovalent cation lithium partially exerts its effects by activating neurotrophic and neuroprotective cellular cascades. Here, we discuss the effects of lithium on oxidative stress …
Abstract Bipolar disorder afflicts approximately 1–3% of both men and women, and is coincident with major economic, societal, medical, and interpersonal consequences. Current …
JA Quiroz, TD Gould, HK Manji - Molecular …, 2004 - triggered.edina.clockss.org
Bipolar affective disorder is a common, severe, chronic, and often life-threatening illness, associated with other medical and psychiatric conditions (ie, co-morbidity). The treatment of …
AA Farooqui, LA Horrocks - The Neuroscientist, 2001 - journals.sagepub.com
Plasmalogens are unique glycerophospholipids because they have an enol ether double bond at the sn-1 position of the glycerol backbone. They are found in all mammalian tissues …
K Suneson, J Lindahl, S Chamli Hårsmar… - International journal of …, 2021 - mdpi.com
Treatment of depression is hampered by the failure to identify distinct symptom profiles with distinct pathophysiologies that differentially respond to distinct treatments. We posit that …